药物安全研究中的综合数据科学:经验,挑战和观点
Ferran Sanz1,2
11Department of Medicine and Life Sciences (MELIS), Universitat Pompeu Fabra, Barcelona, Spain;
Annual review of biomedical data science
|April 1, 2025
概括
在药物安全研究中使用二次数据是有希望的,但面临着互操作性和数据保护等挑战. 像OMOP和VICT3R这样的倡议证明了成功的数据共享,以改善药物开发和安全评估.
科学领域:
- 药监和药物安全 药监和药物安全
- 数据科学在制药领域
- 毒理学研究 毒理学研究
背景情况:
- 制药研发在很大程度上依赖于数据的数量和质量.
- 通过协作和整合方法的二次数据使用显示了药物安全方面的潜力.
- 挑战包括互操作性,知识产权和临床数据隐私.
研究的目的:
- 突出药学研究中二次数据使用的好处和挑战.
- 在临床和毒理学领域展示成功的数据共享倡议.
- 讨论共享数据在非临床药物安全性评估中的应用.
主要方法:
- 对协作和整合数据共享方法的审查.
- 临床数据共享平台的例子 (OMOP,EHDEN,DARWIN EU). 临床数据共享平台的例子.
- 在毒理学领域的企业数据共享的例子 (eTOX,eTRANSAFE,VICT3R).
主要成果:
- 在临床和毒理学研究中存在成功的数据共享计划.
- 在非临床安全评估中,VICT3R项目利用虚拟控制组的共享数据进行非临床安全评估.
- 综合药物相关知识库是药物安全的宝贵工具.
结论:
- 综合数据方法为推进药物安全研究提供了重大前景.
- 克服数据共享方面的挑战对于实现这些方法的全部潜力至关重要.
- 共同的数据和知识库对于高效和有效的药物开发至关重要.
相关概念视频
Drug Regulation
3.0K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
3.0K
Pharmacovigilance
2.0K
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
2.0K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
627
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
627
Bioavailability Study Design: Healthy Subjects Versus Patients
248
Bioavailability studies are essential for evaluating a drug's therapeutic efficacy and understanding its absorption patterns under various physiological conditions. Conducting such studies on target patient populations provides more relevant data by simulating real-world disease states. However, practical challenges often necessitate the use of young, healthy adult volunteers as study subjects.Patients may exhibit altered drug absorption patterns due to the effects of the disease itself,...
248
Drug Toxicity: Risk factors
229
Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
229
Pharmaceutical Poisoning: Potential Scenarios
116
Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
116


